View Filing Data

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2011	Nov. 01, 2011
Entity Registrant Name	PDL BIOPHARMA, INC.
Entity Central Index Key	0000882104
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		139,834,559
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2011

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues:
Royalties	$ 83,370	$ 86,442	$ 278,833	$ 268,846
License and other	400	0	10,400	0
Total revenues	83,770	86,442	289,233	268,846
General and administrative expenses	3,960	11,110	13,516	29,340
Operating income	79,810	75,332	275,717	239,506
Non-operating expense, net:
Gain (loss) on retirement or conversion of convertible notes	0	(2,354)	(766)	(18,681)
Interest and other income	130	167	463	337
Interest and other expense	(9,007)	(9,928)	(27,941)	(34,015)
Total non-operating expense, net	(8,877)	(12,115)	(28,244)	(52,359)
Income before income taxes	70,933	63,217	247,473	187,147
Income tax expense	25,017	23,028	87,026	70,813
Net income	$ 45,916	$ 40,189	$ 160,447	$ 116,334
Net income per share
Net income per basic share (in dollars per share)	$ 0.33	$ 0.32	$ 1.15	$ 0.95
Net income per diluted share (in dollars per share)	0.28	0.24	0.88	0.67
Cash dividends declared per common share (in dollars per share)	$ 0.15	$ 0.50	$ 0.45	$ 0.50
Weighted average shares outstanding
Basic (in shares)	139,680	127,479	139,665	122,209
Diluted (in shares)	167,019	172,217	186,756	178,448

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 157,132	$ 211,574
Short-term investments	37,847	34,658
Receivables from licensees	0	469
Deferred tax assets	13,540	19,902
Prepaid and other current assets	9,677	18,060
Total current assets	218,196	284,663
Property and equipment, net	36	80
Long-term investments	30,356	1,997
Long-term deferred tax assets	14,033	22,620
Other assets	7,904	7,306
Total assets	270,525	316,666
Current liabilities:
Accounts payable	272	2,540
Accrued legal settlement	27,500	65,000
Accrued liabilities	30,528	7,204
Current portion of non-recourse notes payable	115,268	119,247
Total current liabilities	173,568	193,991
Convertible notes payable	315,368	310,428
Non-recourse notes payable	0	85,023
Other long-term liabilities	24,828	51,406
Total liabilities	513,764	640,848
Commitments and contingencies (Note 11)
Stockholders' deficit:
Preferred stock, par value $0.01 per share, 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, par value $0.01 per share, 250,000 shares authorized; 139,815 and 139,640 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively	1,397	1,396
Additional paid-in capital	(161,889)	(87,373)
Accumulated other comprehensive income (loss)	(1,770)	3,219
Accumulated deficit	(80,977)	(241,424)
Total stockholders' deficit	(243,239)	(324,182)
Total liabilities and stockholders' deficit	$ 270,525	$ 316,666

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares shares in Thousands	Sep. 30, 2011	Dec. 31, 2010
Balance Sheet [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	10,000	10,000
Preferred stock, issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	250,000	250,000
Common stock, issued (in shares)	139,680	139,640
Common stock, outstanding (in shares)	139,680	139,640

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities
Net income	$ 160,447	$ 116,334
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of convertible notes offering costs	3,592	1,210
Amortization of non-recourse notes offering costs	3,750	5,567
Other amortization and depreciation expense	1,032	185
Loss on retirement or conversion of convertible notes	766	18,681
Stock-based compensation expense	256	525
Tax (expense) benefit from stock-based compensation arrangements	(120)	10,012
Net excess tax benefit from stock-based compensation	0	(10,302)
Deferred income taxes	25,117	(5,679)
Changes in assets and liabilities:
Receivables from licensees	469	800
Prepaid and other current assets	1,881	5,823
Other assets	(6,642)	142
Accounts payable	(2,655)	918
Accrued liabilities and other long-term liabilities	(25,757)	10,097
Accrued legal settlement	(37,500)	0
Net cash provided by operating activities	124,636	154,313
Cash flows from investing activities
Purchases of investments	(71,697)	(28,810)
Maturities of investments	39,146	2,000
Net cash provided used in investing activities	(32,551)	(26,810)
Cash flows from financing activities
Repurchase of convertible notes	(134,464)	(105,723)
Repayment of non-recourse notes	(89,002)	(74,959)
Cash dividend paid	(62,876)	(59,864)
Net proceeds from the issuance of convertible notes	149,712	0
Purchase of call options	(20,765)	0
Proceeds from issue of warrants	10,868	0
Net excess tax benefit from stock-based compensation	0	10,302
Net cash used in financing activities	(146,527)	(230,244)
Net decrease in cash and cash equivalents	(54,442)	(102,741)
Cash and cash equivalents at beginning of the period	211,574	303,227
Cash and cash equivalents at end of the period	157,132	200,486
Supplemental cash flow information
Cash paid for income taxes	66,000	48,000
Cash paid for interest	$ 20,004	$ 34,440
Issuance of Common Shares for Stock Based Compensation [Member]
Supplemental disclosures of non-cash activities
Issuance of common shares for stock based compensation (in shares)	135	40
Issuance of Common Shares for Conversion of Convertible Notes [Member]
Supplemental disclosures of non-cash activities
Issuance of common shares for conversion of convertible notes (in shares)	0	19,969

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2011

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments (consisting only of normal recurring adjustments) the management of PDL BioPharma, Inc. (the Company, PDL, we, us or our) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.

The accompanying Condensed Consolidated Financial Statements and related financial information should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December 31, 2010, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. The Condensed Consolidated Balance Sheet at December 31, 2010, has been derived from the audited Consolidated Financial Statements at that date.

Principles of Consolidation

The Consolidated Financial Statements include the accounts of PDL and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

Customer Concentration

Revenues from our licensees' products, which individually accounted for 10% or more of our total royalty revenues, were:

		Three Months Ended						Nine Months Ended
		September 30,						September 30,
Licensee	Product Name	2011			2010			2011			2010
Genentech, Inc. (Genentech)	Avastin®		29	%		35	%		32	%		34	%
	Herceptin®		38	%		32	%		36	%		33	%
	Lucentis®		15	%		13	%		16	%		14	%


Elan Corporation, Plc (Elan)	Tysabri®		14	%		10	%		12	%		10	%

Revenue Recognition

Under most of our patent license agreements, we receive royalty payments based upon our licensees' net sales of covered products. Generally, under these agreements we receive royalty reports and payments from our licensees approximately one quarter in arrears, that is, generally in the second month of the quarter after the licensee has sold the royalty bearing product or products. We recognize royalty revenues when we can reliably estimate such amounts and collectability is reasonably assured. As such, we generally recognize royalty revenues in the quarter reported to us by our licensees, that is, royalty revenues are generally recognized one quarter following the quarter in which sales by our licensees occurred. Under this accounting policy, the royalty revenues we report are not based upon our estimates and are typically reported in the same period in which we receive payment from our licensees.

We may also receive minimal annual maintenance fees from licensees of our Queen et al. patents prior to patent expiry as well as periodic milestone payments. We have no performance obligations with respect to such fees. Maintenance fees are recognized as they are due and when payment is reasonably assured. Total annual milestone payments in each of the last several years have been less than 1% of total revenue.

Foreign Currency Hedging

We hedge certain Eurodollar currency exposures related to our licensees' product sales with Eurodollar forward contracts and Eurodollar option contracts (collectively, Eurodollar contracts). In general, these contracts are intended to offset the underlying Eurodollar market risk in our royalty revenues. We do not enter into speculative foreign currency transactions. We have designated the Eurodollar contracts as cash flow hedges. At the inception of the hedging relationship and on a quarterly basis, we assess hedge effectiveness.

The fair value of the Eurodollar contracts is estimated using pricing models with readily observable inputs from actively quoted markets. The aggregate unrealized gain or loss on our foreign currency exchange contracts, net of estimated taxes, on the effective portion of the hedge is recorded in stockholders' deficit as accumulated other comprehensive income (loss). Gains or losses on cash flow hedges are recognized as royalty revenue in the same period that the hedged transaction, royalty revenue, impacts earnings. The hedge effectiveness is dependent upon the amounts of future royalties. If future royalties based on Eurodollar are lower than forecasted, the amount of ineffectiveness would be reported in our Condensed Consolidated Statements of Income.

Recently Issued Accounting Pronouncements

The Financial Accounting Standards Board recently issued accounting standard update (ASU) 2011-05, eliminating the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. The update requires presentation for items of net income and other comprehensive income either in one continuous statement or in two separate, but consecutive, statements. This ASU also includes a new requirement to show reclassification adjustments from other comprehensive income to net income on the face of the statement. This guidance is required for our first quarter of 2012 with retrospective application also required. We do not expect the adoption of this guidance to have a material effect on our consolidated financial statements.

Net Income per Share

9 Months Ended

Sep. 30, 2011

Net Income per Share [Abstract]

Net Income per Share

2. Net Income per Share

We compute net income per basic share using the weighted-average number of shares of common stock outstanding during the period less the weighted-average number of restricted stock shares subject to repurchase.

We compute net income per diluted share using the sum of the weighted-average number of common and common-equivalent shares outstanding. Common-equivalent shares used in the computation of net income per diluted share include shares that may be issued under our stock option and restricted stock awards, our 2.00% Convertible Senior Notes due February 15, 2012 (2012 Notes), our 2.875% Convertible Senior Notes due February 15, 2015 (February 2015 Notes), and our 2.75% Convertible Subordinated Notes due August 16, 2023 (2023 Notes), on a weighted average basis for the period that the notes were outstanding, including the effect of adding back interest expense and the underlying shares using the if-converted method. The 2023 Notes were fully retired or converted as of September 14, 2010. The 2012 Notes were fully retired as of June 30, 2011.

The computation for net income per basic and diluted share was:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In thousands)	2011		2010		2011		2010
Numerator
Net income	$	45,916	$	40,189	$	160,447	$	116,334
Add back interest expense for implied conversion of convertible notes, net of estimated tax of $0.5 million for each of the three months ended September 30, 2011 and 2010, respectively, and $1.8 million and $2.1 million for the nine months ended September 30, 2011 and 2010, respectively (see Note 9)		841		987		3,391		3,982
Income used to compute net income per diluted share	$	46,757	$	41,176	$	163,838	$	120,316

Denominator
Total weighted-average shares used to compute net income per basic share		139,680		127,479		139,665		122,209
Effect of dilutive stock options		13		10		13		9
Restricted stock outstanding		12		106		21		99
Assumed conversion of 2012 Notes		-		32,050		19,743		32,050
Assumed conversion of February 2015 Notes		27,314		-		27,314		-
Assumed conversion of 2023 Notes		-		12,572		-		24,081
Shares used to compute income per diluted share		167,019		172,217		186,756		178,448

Net income per basic share	$	0.33	$	0.32	$	1.15	$	0.95
Net income per diluted share	$	0.28	$	0.24	$	0.88	$	0.67

We have excluded 0.2 million of outstanding stock options from our net income per diluted share calculations for the three months ended September 30, 2011, and 2010, respectively, and we have excluded 0.2 million and 0.4 million of outstanding stock options from our net income per diluted share for the nine months ended September 30, 2011, and 2010, respectively, because the option exercise prices were greater than the average market prices of our common stock during these periods; therefore, the shares were not dilutive.

In May 2011, we issued 3.75% Senior Convertible Notes due May 1, 2015 (May 2015 Notes). If converted, the principal amount of the May 2015 Notes will be settled in cash and the excess of the conversion value over the principal amount will be settled with shares of the Company's common stock. For the periods presented, no stock was issuable upon conversion; therefore, the May 2015 Notes have been excluded for purposes of computing net income per diluted share.

Concurrent with the issuance of the May 2015 Notes, the Company entered into privately negotiated purchased call option transactions. The purchased call option transactions cover, subject to customary anti-dilution adjustments, the number of shares of the Company's common stock that underlie the May 2015 Notes and are intended to reduce the dilutive impact of the conversion feature of the May 2015 Notes. Purchased call options are anti-dilutive and have been excluded from the determination of net income per diluted share.

To reduce the hedging costs of the purchased call options, the Company also entered into privately negotiated warrant transactions. The warrant transactions could have a dilutive effect to the extent that the market price per share of the Company's common stock exceeds the applicable strike price of the warrants on any expiration date of the warrants. For the periods shown above, the strike price on the warrants exceeded the market price of the warrants and, accordingly, the warrants have been excluded from the determination of net income per diluted share.

Fair Value Measurements

9 Months Ended

Sep. 30, 2011

Fair Value Measurements [Abstract]

Fair Value Measurements

3. Fair Value Measurements

The fair value of our financial instruments are estimates of the amounts that would be received if we were to sell an asset or we paid to transfer a liability in an orderly transaction between market participants at the measurement date or exit price. The assets and liabilities are categorized and disclosed in one of the following three categories:

Level 1 – based on quoted market prices in active markets for identical assets and liabilities;

Level 2 – based on quoted market prices for similar assets and liabilities, using observable market based inputs or unobservable market based inputs corroborated by market data; and

Level 3 – based on unobservable inputs using management's best estimate and assumptions when inputs are unavailable. As of September 30, 2011, and December 31, 2010, we had no Level 3 assets or liabilities.

The following table summarizes assets and liabilities recorded at fair value by classification category:

	September 30, 2011						December 31, 2010
(In thousands)	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	151,497	$	-	$	151,497	$	203,318	$	-	$	203,318
Corporate debt securities		49,523		-		49,523		20,434		-		20,434
Commercial paper		-		6,943		6,943		-		7,998		7,998
U.S. government sponsored agency bonds		6,223		-		6,223		8,725		-		8,725
U.S. treasury securities		5,514		-		5,514		1,997		-		1,997
Foreign currency hedge contracts		-		11,174		11,174		-		17,763		17,763
Total	$	212,757	$	18,117	$	230,874	$	234,474	$	25,761	$	260,235

Liabilities:
Foreign currency hedge contracts	$	-	$	13,883	$	13,883	$	-	$	12,810	$	12,810

The fair value of commercial paper is estimated based on observable inputs of comparable securities.

The fair value of the foreign currency hedging contracts is estimated based on pricing models using readily observable inputs from actively quoted markets and are disclosed on a gross basis.

We do not estimate the fair value of our royalty assets for financial statement reporting purposes.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

+ Details

Cash Equivalents, Short-term and Long-term Investments

9 Months Ended

Sep. 30, 2011

Cash Equivalents, Short-term and Long-term Investments [Abstract]

Cash Equivalents, Short-term and Long-term Investments

4. Cash Equivalents, Short-term and Long-term Investments

Our investments are classified as available-for-sale and are carried at estimated fair value, with unrealized gains and losses, net of estimated taxes, reported in accumulated other comprehensive income (loss) in stockholders' deficit. See Note 3 for fair value measurement information. The cost of securities sold is based on the specific identification method. To date, we have not experienced credit losses on investments in these instruments and we do not require collateral for our investment activities.

A summary of our available-for-sale securities is presented below:

			Gross		Gross			Estimated
	Amortized		Unrealized		Unrealized			Fair
September 30, 2011:	Cost		Gains		Losses			Value
(In thousands)
Money market funds	$	151,497	$	-	$	-		$	151,497
Corporate debt securities		49,573		27		(77	)		49,523
Commercial paper		6,944		-		(1	)		6,943
U.S. government sponsored agency bonds		6,209		14		-			6,223
U.S. treasury securities		5,493		21		-			5,514
Total	$	219,716	$	62	$	(78	)	$	219,700

December 31, 2010:
(In thousands)
Money market funds	$	203,318	$	-	$	-		$	203,318
Corporate debt securities		20,437		2		(5	)		20,434
Commercial paper		7,998		-		-			7,998
U.S. government sponsored agency bonds		8,727		-		(2	)		8,725
U.S. treasury securities		1,994		3		-			1,997
Total	$	242,474	$	5	$	(7	)	$	242,472

					September 30,			December 31,
Classification on Consolidated Balance Sheets:					2011			2010
(In thousands)
Cash equivalents					$	151,497		$	205,817
Short-term investments						37,847			34,658
Long-term investments						30,356			1,997
Total					$	219,700		$	242,472

Available-for-sale debt securities by contractual maturity:	September 30, 2011				December 31, 2010
(In thousands)	Amortized		Fair		Amortized			Fair
	Cost		Value		Cost			Value
Less than one year	$	37,852	$	37,847	$	37,162		$	37,157
Greater than one year but less than five years		30,367		30,356		1,994			1,997
Total	$	68,219	$	68,203	$	39,156		$	39,154

During the nine months ended September 30, 2011, and the year ended December 31, 2010, we did not recognize any gains or losses on sales of available-for-sale securities.

No significant facts or circumstances have arisen to indicate that there has been any deterioration in the creditworthiness of the issuers of these securities. Based on our review of these securities, we believe we had no other-than-temporary impairments on these securities as of September 30, 2011, because it is more likely than not that we will hold these securities until the recovery of their amortized cost basis.

- Definition

Tabular disclosure of investments in certain debt and equity securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes. A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 115
-Paragraph 3, 19, 20, 21, 22, 137
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27161-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27357-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27290-111563

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27405-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27232-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Debt Security
-URI http://asc.fasb.org/extlink&oid=6509901
-Topic 320

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Equity Security
-URI http://asc.fasb.org/extlink&oid=6511694
-Topic 320

+ Details

Foreign Currency Hedging

9 Months Ended

Sep. 30, 2011

Foreign Currency Hedging [Abstract]

Foreign Currency Hedging

5. Foreign Currency Hedging

Our licensees operate in foreign countries, which exposes us to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and other currencies, primarily the Eurodollar. In order to manage the risk related to changes in foreign currency exchange rates, we entered into a series of Eurodollar contracts in 2010 covering the quarters in which our licensees' sales occur through December 2012. Our Eurodollar contracts used to hedge royalty revenues which are based on underlying Eurodollar sales are designated as cash flow hedges.

The following table summarizes the notional amounts, Eurodollar exchange rates and fair values of our open Eurodollar contracts designated as cash flow hedges:

				September 30, 2011					December 31, 2010
Eurodollar Forward Contracts				(in thousands)					(in thousands)

Currency	Settlement Price ($ per Eurodollar)		Type	Notional Amount		Fair Value			Notional Amount		Fair Value
Eurodollar		1.400	Sell Eurodollar	$	50,205	$	1,838		$	137,179	$	6,740
Eurodollar		1.200	Sell Eurodollar		117,941		(13,883	)		117,941		(12,810	)
Total				$	168,146	$	(12,045	)	$	255,120	$	(6,070	)

Eurodollar Option Contracts

Currency	Strike Price ($ per Eurodollar)		Type	Notional Amount		Fair Value		Notional Amount		Fair Value
Eurodollar		1.510	Purchased call option	$	54,150	$	46	$	147,957	$	772
Eurodollar		1.315	Purchased call option		129,244		9,290		129,244		10,251
Total				$	183,394	$	9,336	$	277,201	$	11,023

The following table summarizes information about the fair value of our Eurodollar contracts on our Condensed Consolidated Balance Sheets:

		Fair Value (In thousands)
Cash Flow Hedge	Location	September 30, 2011		December 31, 2010
Eurodollar contracts, net	Prepaid and other current assets	$	797	$	5,946
Eurodollar contracts, net	Accrued liabilities		1,993		-
Eurodollar contracts, net	Other long-term liabilities		1,513		993

Eurodollar contracts are presented on a net basis on our Condensed Consolidated Balance Sheets as we have entered into a netting arrangement with the counterparty. As of September 30, 2011, the unrealized net loss on the effective component of our Eurodollar contracts included in other comprehensive income (loss), net of estimated taxes, was $1.8 million. As of December 31, 2010, the unrealized net gain on the effective component of our Eurodollar contracts included in other comprehensive income (loss), net of estimated taxes, was $3.2 million.

We recognized a $0.7 million loss in royalty revenue due to settled Eurodollar contracts for the three months ended September 30, 2011. We recognized a $0.2 million gain in royalty revenue due to settled Eurodollar contracts for the nine months ended September 30, 2011. For the three and nine months ended September 30, 2010, we recognized gains of $2.9 million and $4.5 million, respectively, in royalty revenue due to settled Eurodollar contracts. Approximately $0.8 million in revenue is expected to be reclassified from other comprehensive income (loss) into earnings in the next 12 months.

- Definition

The entire disclosure for the entity's entire derivative instruments and hedging activities. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6887037&loc=d3e80784-113994

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579245-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624163-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41638-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5580258-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579240-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41641-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41620-113959

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624181-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624177-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6887037&loc=d3e80748-113994

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624258-113959

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5708775-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41635-113959

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5708773-113959

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

+ Details

Prepaid and Other Current Assets

9 Months Ended

Sep. 30, 2011

Prepaid and Other Current Assets [Abstract]

Prepaid and Other Current Assets

6. Prepaid and Other Current Assets

	September 30,		December 31,
(In thousands)	2011		2010
Non-recourse Notes issuance costs	$	2,009	$	3,362
Foreign exchange hedge		797		5,946
Prepaid taxes		6,051		8,307
Other		820		445
Total prepaid and other current assets	$	9,677	$	18,060

Other Assets

9 Months Ended

Sep. 30, 2011

Other Assets, Noncurrent Disclosure [Abstract]

Other Assets

7. Other Assets

	September 30,		December 31,
(In thousands)	2011		2010
2012 Notes issuance costs	$	-	$	683
February 2015 Notes issuance costs		3,463		4,226
May 2015 Notes issuance costs		4,427		-
Non-recourse Notes issuance costs		-		2,397
Other assets, net		14		-
Total other assets	$	7,904	$	7,306

Accrued Liabilities

9 Months Ended

Sep. 30, 2011

Accrued Liabilities [Abstract]

Accrued Liabilities

8. Accrued Liabilities

	September 30,		December 31,
(In thousands)	2011		2010
Dividend payable	$	21,012	$	20
Foreign currency hedge		1,993		-
Compensation		1,369		349
Interest		3,370		2,794
Deferred revenue		1,713		1,713
Other		1,071		2,328
Total accrued liabilities	$	30,528	$	7,204

Convertible and Non-Recourse Notes

9 Months Ended

Sep. 30, 2011

Convertible and Non-Recourse Notes [Abstract]

Convertible and Non-Recourse Notes

9. Convertible and Non-Recourse Notes

Convertible and non-recourse notes activity for the nine months ended September 30, 2011, and fair values at September 30, 2011:

(In thousands)	2012 Notes			February 2015 Notes		May 2015 Notes		Non-recourse Notes			Total
Balance at December 31, 2010	$	133,464		$	176,964	$	-	$	204,270		$	514,698
Issuance		-			-		136,313		-			136,313
Payment		-			-		-		(89,002	)		(89,002	)
Redemption		(133,464	)		-		-		-			(133,464	)
Discount amortization		-			521		1,570		-			2,091
Balance at September 30, 2011	$	-		$	177,485	$	137,883	$	115,268		$	430,636

Fair value(1)	$	-		$	178,650	$	146,420	$	117,573		$	442,643

(1)

As of September 30, 2011, the fair value of the remaining payments under our Convertible notes and Non-recourse Notes was estimated based on the trading value of our notes then outstanding.

PDL was in compliance with all applicable debt covenants at September 30, 2011. Embedded features of all debt agreements were evaluated and did not need to be accounted for separately at September 30, 2011.

May 2015 Notes

On May 16, 2011, we issued $155.3 million in aggregate principal amount, at par, of the May 2015 Notes in an underwritten public offering, for net proceeds of $149.7 million. The May 2015 Notes are due May 1, 2015, and are convertible into 132.6682 shares of the Company's common stock per $1,000 of principal amount, or approximately $7.54 per share, subject to further adjustment upon certain events including dividend payments. We pay interest at 3.75% on the May 2015 Notes semiannually in arrears on May 1 and November 1 of each year, beginning November 1, 2011. Proceeds from the May 2015 Notes, net of amounts used for purchased call option transactions and funds provided by the warrant transactions described below, were used to redeem the 2012 Notes. Upon the occurrence of a fundamental change, as defined in the indenture, holders have the option to require PDL to repurchase their May 2015 Notes at a purchase price equal to 100% of the principal, plus accrued interest.

The May 2015 Notes are convertible under any of the following circumstances:

During the five business-day period immediately after any five consecutive trading-day period, which we refer to as the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of that measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the notes for each such day; or

Upon the occurrence of specified corporate events as described further in the indenture at any time on or after November 1, 2014.

If a conversion occurs, to the extent that the conversion value exceeds the principal amount, the principal amount is due in cash and the difference between the conversion value and the principal amount is due in shares of the Company's common stock. As of September 30, 2011, the if-converted amount of the May 2015 Notes was less than the principal amount.

In accordance with the accounting guidance for convertible debt instruments that may be settled in cash or other assets on conversion, we were required to separately account for the liability component of the instrument in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. As a result, we separated the principal balance of the May 2015 Notes between the fair value of the debt component and the fair value of the common stock conversion feature. Using an assumed borrowing rate of 7.5%, which represents the estimated market interest rate for a similar nonconvertible instrument available to us on the date of issuance, we recorded a total debt discount of $18.9 million, allocated $12.3 million to additional paid-in capital and $6.6 million to deferred tax liability. The discount is being amortized to interest expense over the term of the May 2015 Notes and increases interest expense during the term of the May 2015 Notes from the 3.75% cash coupon interest rate to an effective interest rate of 7.5%. The fair value of the common stock conversion feature of $12.3 million is recorded as a component of stockholders' deficit. As of September 30, 2011, the remaining discount amortization period is 3.6 years.

The carrying value and unamortized discount of the May 2015 Notes were:

(In thousands)	September 30, 2011
Principal amount of the May 2015 Notes	$	155,250
Unamortized discount of liability component		(17,367	)
Net carrying value of the May 2015 Notes	$	137,883

Interest expense for the May 2015 Notes included in Interest and other expense, net on the Condensed Consolidated Statements of Income was:

(In thousands)	For the Period May 16 to September 30, 2011
Contractual coupon interest	$	2,183
Amortization of debt issuance costs		434
Amortization of debt discount		1,570
Total	$	4,187

In connection with the issuance of the May 2015 Notes, we entered into purchased call option transactions with two hedge counterparties entitling the Company to initially purchase up to 19.6 million shares of the Company's common stock. In addition, we sold to the hedge counterparties warrants exercisable, on a cashless basis, for up to 27.5 million shares of the Company's common stock. The purchased call option transactions and warrant sales effectively serve to reduce the potential dilution associated with conversion of the May 2015 Notes. The strike prices at September 30, 2011, were approximately $7.54 and $8.87, subject to further adjustment upon certain events including dividend payments, for the purchased call options and warrants, respectively.

If the share price is above $7.54, upon conversion of the May 2015 Notes, the purchased call options will offset the share dilution, because the Company will receive shares on exercise of the purchased call options equal to the shares that the Company must deliver to the note holders. If the share price is above $8.87, upon exercise of the warrants, the Company will deliver shares to the counterparties in an amount equal to the excess of the share price over $8.87. For example, a 10% increase in the share price above $8.87 would result in the issuance of 1.9 million incremental shares upon exercise of the warrants. As our share price continues to increase, additional dilution would occur.

While the purchased call options are expected to reduce the potential equity dilution upon conversion of the May 2015 Notes, prior to conversion or exercise, the May 2015 Notes and the warrants could have a dilutive effect on the Company's earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the respective exercise prices of those instruments.

The purchased call options and warrants are considered indexed to PDL stock, require net-share settlement, and met all criteria for equity classification at inception and at September 30, 2011. The purchased call options cost of $20.7 million, net of deferred taxes of $7.2 million, and $10.9 million received for the warrants were recorded as adjustments to additional paid-in capital. Subsequent changes in fair value will not be recognized as long as the purchased call options and warrants continue to meet the criteria for equity classification.

Purchased Call Options

We paid an aggregate amount of $20.7 million to two hedge counterparties for the purchased call options with terms substantially similar to the embedded conversion options in the May 2015 Notes. The purchased call options cover, subject to anti-dilution and certain other customary adjustments substantially similar to those in the May 2015 Notes, approximately 20.6 million shares of our common stock at a strike price of approximately $7.54, which corresponds to the conversion price of the May 2015 Notes. We may exercise the purchased call options upon conversion of the May 2015 Notes and require the hedge counterparty to deliver shares to the Company in an amount equal to the shares required to be delivered by the Company to the note holder for the excess conversion value. The purchased call options expire on May 1, 2015, or the last day any of the May 2015 Notes remain outstanding.

Warrants

We received an aggregate amount of $10.9 million from the two hedge counterparties for the sale of rights to receive up to 27.5 million shares of common stock underlying the May 2015 Notes, at a current strike price of approximately $8.87 per share, subject to additional anti-dilution and certain other customary adjustments. The warrant counterparties may exercise the warrants on their specified expiration dates that occur over a period of time ending on January 20, 2016. If the volume weighted average share price of our common stock, as defined in the warrants (VWAP), exceeds the strike price of the warrants, we will deliver to the warrant counterparties shares equal to the spread between the VWAP on the date of exercise or expiration and the strike price. If the VWAP is less than the strike price, neither party is obligated to deliver anything to the other.

2012 Notes

On June 30, 2011, we redeemed the $133.5 million in aggregate principal outstanding of 2012 Notes, at a redemption price of 100.29% of face value for aggregate consideration of $133.9 million plus interest of $1.0 million. With the completion of this redemption on June 30, 2011, the 2012 Notes were fully retired.

Other Long-Term Liabilities

9 Months Ended

Sep. 30, 2011

Other Long-Term Liabilities [Abstract]

Other Long-Term Liabilities

10. Other Long-Term Liabilities

	September 30,		December 31,
(In thousands)	2011		2010
Accrued lease liability	$	10,700	$	10,700
Accrued legal settlement		-		27,500
Uncertain tax position		12,615		12,213
Foreign currency hedge		1,513		993
Total	$	24,828	$	51,406

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2011
Commitments and Contingencies [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Genentech Matter In August 2010, we received a letter from Genentech, sent on behalf of F. Hoffman-La Roche Ltd. (Roche) and Novartis AG (Novartis), indicating that they believe that sales of their products that are both manufactured and sold outside of the United States do not infringe our supplementary protection certificates (SPCs) granted to us by various countries in Europe. Our SPCs generally extend the patent protection for our European Patent No. 0 451 216B (‘216B Patent) until December 2014, except that the SPCs for Herceptin will generally expire in July 2014. In response, we filed a complaint against Genentech, Roche and Novartis in Nevada, as we believe that a settlement agreement reached in 2003 between Genentech and us resolved all patent disputes between the two companies at that time. The matter is still ongoing with Genentech and Roche; however, we reached a settlement agreement with Novartis in early 2011. On July 7, 2011, the Second Judicial District Court of Nevada denied motions made by Genentech and Roche to dismiss four of PDL's claims for relief relating to the 2003 settlement agreement with Genentech and, further, denied Roche's motion to dismiss for lack of personal jurisdiction. The court dismissed one of PDL's claims that Genentech committed a bad-faith breach of the covenant of good faith and fair dealing with regard to the 2003 settlement agreement stating that, on the current state of pleadings, no “special relationship” had been established between Genentech and PDL, as required under Nevada law. The effect of the Court's ruling is that PDL is permitted to continue to pursue its claims that (i) Genentech is obligated to pay royalties to PDL on international sales of the Genentech Products; (ii) Genentech, by challenging, at the behest of Roche and Novartis, whether PDL's SPCs cover the Genentech Products, breached its contractual obligations to PDL under the 2003 settlement agreement; (iii) Genentech breached the implied covenant of good faith and fair dealing with respect to the 2003 settlement agreement and (iv) Roche intentionally and knowingly interfered with PDL's contractual relationship with Genentech in conscious disregard of PDL's rights. PDL seeks compensatory damages, including liquidated damages and other monetary remedies set forth in the 2003 settlement agreement, punitive damages and attorney's fees as a result of Genentech and Roche's conduct. The ultimate outcome of this litigation is uncertain and we may not be successful in our allegations. Novartis Settlement In February 2011, we reached a settlement with Novartis under which we agreed to dismiss our claims against Novartis in the action in Nevada state court, which also includes Genentech and Roche as defendants, and Novartis agreed to withdraw its opposition appeal in the European Patent Office challenging the validity of the ‘216B Patent. Under the settlement agreement with Novartis, after receipt of our royalty payment for sales of Lucentis each quarter, we pay Novartis a portion of the royalties that we receive for Lucentis sales made by them. Lease Guarantee In connection with the divestiture of our former biotechnology subsidiary, Facet Biotech Corporation (Facet), we entered into amendments to the leases for our former facilities in Redwood City, California, under which Facet was added as a co-tenant, and a Co-Tenancy Agreement, under which Facet agreed to indemnify us for all matters related to the leases attributable to the period after the divestiture. Should Facet default under the lease obligations, we would be held liable by the landlord as a co-tenant and, thus, we have in substance guaranteed the payments under the lease agreements for the Redwood City facilities. As of September 30, 2011, the total lease payments for the duration of the guarantee, which runs through December 2021, were approximately $113.4 million. We would also be responsible for lease related costs including utilities, property taxes and common area maintenance which may be as much as the actual lease payments if Facet defaulted. In April 2010, Abbott Laboratories acquired Facet and later renamed the company Abbott Biotherapeutics Corp. We recorded a liability of $10.7 million on our Condensed Consolidated Balance Sheets as of September 30, 2011, and December 31, 2010, related to the estimated fair value of this guarantee.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Stock-Based Compensation

9 Months Ended

Sep. 30, 2011

Stock-Based Compensation [Abstract]

Stock-Based Compensation

12. Stock-Based Compensation

Stock-based compensation expense for the three and nine months ended September 30, 2011, and 2010, was:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(In thousands)	2011			2010			2011			2010
General and administrative expenses	$	132		$	166		$	256		$	525
Income tax effect		(46	)		(58	)		(90	)		(184	)
Stock-based compensation expense included in net income	$	86		$	108		$	166		$	341

During the three months ended September 30, 2011, the Company awarded a grant of 20,000 shares of restricted stock, subject to vesting conditions, to a consultant. During the nine months ended September 30, 2011, the Company awarded approximately 135,000 shares of restricted stock, subject to vesting conditions, to directors, employees and a consultant.

During the nine months ended September 30, 2010, the Company awarded approximately 40,000 shares of restricted stock, subject to vesting conditions, to directors. Additionally, approximately 1.3 million fully vested stock options with an average exercise price of $20.36 per share were forfeited and expired unexercised.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

+ Details

Cash Dividends	9 Months Ended
Cash Dividends	Sep. 30, 2011
Cash Dividends [Abstract]
Cash Dividends	13. Cash Dividends On February 25, 2011, our board of directors declared a regular quarterly dividend of $0.15 per share of common stock, payable March 15, June 15, September 15 and December 15 of 2011 to stockholders of record on March 8, June 8, September 8 and December 8 of 2011, the record dates of each of the dividend payment dates, respectively. We paid $21.0 million to our stockholders on each of March 15, June 15, and September 15, 2011, using current year earnings and cash on hand. As of September 30, 2011, we have accrued $21.0 million in dividends payable for the December 15, 2011, dividend. In connection with the payment of the dividend on September 15, 2011, the conversion ratios for our convertible notes increased. The conversion ratio for the February 2015 Notes was adjusted to 151.713 shares per $1,000 principal amount, or approximately $6.59 per share, effective September 9, 2011. The conversion ratio for our May 2015 Notes was adjusted to 132.6682 shares per $1,000 principal amount, or approximately $7.54 per share, effective September 6, 2011.

Comprehensive Income

9 Months Ended

Sep. 30, 2011

Comprehensive Income [Abstract]

Comprehensive Income

14. Comprehensive Income

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(In thousands)	2011			2010			2011			2010
Net income	$	45,916		$	40,189		$	160,447		$	116,334
Other comprehensive income (loss):
Unrealized gain (loss) on foreign currency exchange contracts, net of taxes		4,281			(15,747	)		(4,981	)		1,341
Unrealized gain (loss) on investments, net of taxes		(55	)		10			(8	)		2
Total comprehensive income	$	50,142		$	24,452		$	155,458		$	117,677

- Definition

The entire disclosure for comprehensive income. Includes, but is not limited to, the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 14-26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e709-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e640-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e716-108580

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e689-108580

+ Details

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2011
Income Taxes [Abstract]
Income Taxes	15. Income Taxes Income tax expense was $25.0 million and $87.0 million for the three months and nine months ended September 30, 2011, respectively, and was primarily determined by applying the federal statutory rate of 35% to Income before income taxes. Income tax expense was $23.0 million and $70.8 million for the three and nine months ended September 30, 2010, respectively, and was primarily determined by applying the federal statutory income tax rate of 35% to Income before income taxes, adjusted for a portion of the premium paid for the repurchase of our 2023 Notes that was not tax deductible.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2011
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments (consisting only of normal recurring adjustments) the management of PDL BioPharma, Inc. (the Company, PDL, we, us or our) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period. The accompanying Condensed Consolidated Financial Statements and related financial information should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December 31, 2010, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. The Condensed Consolidated Balance Sheet at December 31, 2010, has been derived from the audited Consolidated Financial Statements at that date.
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of PDL and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.
Revenue Recognition	Revenue Recognition Under most of our patent license agreements, we receive royalty payments based upon our licensees' net sales of covered products. Generally, under these agreements we receive royalty reports and payments from our licensees approximately one quarter in arrears, that is, generally in the second month of the quarter after the licensee has sold the royalty bearing product or products. We recognize royalty revenues when we can reliably estimate such amounts and collectability is reasonably assured. As such, we generally recognize royalty revenues in the quarter reported to us by our licensees, that is, royalty revenues are generally recognized one quarter following the quarter in which sales by our licensees occurred. Under this accounting policy, the royalty revenues we report are not based upon our estimates and are typically reported in the same period in which we receive payment from our licensees. We may also receive minimal annual maintenance fees from licensees of our Queen et al. patents prior to patent expiry as well as periodic milestone payments. We have no performance obligations with respect to such fees. Maintenance fees are recognized as they are due and when payment is reasonably assured. Total annual milestone payments in each of the last several years have been less than 1% of total revenue.
Foreign Currency Hedging	Foreign Currency Hedging We hedge certain Eurodollar currency exposures related to our licensees' product sales with Eurodollar forward contracts and Eurodollar option contracts (collectively, Eurodollar contracts). In general, these contracts are intended to offset the underlying Eurodollar market risk in our royalty revenues. We do not enter into speculative foreign currency transactions. We have designated the Eurodollar contracts as cash flow hedges. At the inception of the hedging relationship and on a quarterly basis, we assess hedge effectiveness. The fair value of the Eurodollar contracts is estimated using pricing models with readily observable inputs from actively quoted markets. The aggregate unrealized gain or loss on our foreign currency exchange contracts, net of estimated taxes, on the effective portion of the hedge is recorded in stockholders' deficit as accumulated other comprehensive income (loss). Gains or losses on cash flow hedges are recognized as royalty revenue in the same period that the hedged transaction, royalty revenue, impacts earnings. The hedge effectiveness is dependent upon the amounts of future royalties. If future royalties based on Eurodollar are lower than forecasted, the amount of ineffectiveness would be reported in our Condensed Consolidated Statements of Income.

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 5, 6, 16-19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 20
-Subparagraph a(2)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 96-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 97-2
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 3A
-Section 02, 03

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 40
-Section 45
-URI http://asc.fasb.org/section&trid=2197723

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=6959686&loc=d3e355033-122828

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6382870&loc=d3e33801-111570

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

+ Details

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References + Details

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2011

Summary of Significant Accounting Policies [Abstract]

Revenue Concentration by Licensee by Product Name

Revenues from our licensees' products, which individually accounted for 10% or more of our total royalty revenues, were:

		Three Months Ended						Nine Months Ended
		September 30,						September 30,
Licensee	Product Name	2011			2010			2011			2010
Genentech, Inc. (Genentech)	Avastin®		29	%		35	%		32	%		34	%
	Herceptin®		38	%		32	%		36	%		33	%
	Lucentis®		15	%		13	%		16	%		14	%


Elan Corporation, Plc (Elan)	Tysabri®		14	%		10	%		12	%		10	%

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References + Details

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2011

Stock-Based Compensation [Abstract]

Stock-based compensation expense for employees and directors

Stock-based compensation expense for the three and nine months ended September 30, 2011, and 2010, was:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(In thousands)	2011			2010			2011			2010
General and administrative expenses	$	132		$	166		$	256		$	525
Income tax effect		(46	)		(58	)		(90	)		(184	)
Stock-based compensation expense included in net income	$	86		$	108		$	166		$	341

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References + Details

Net Income per Share (Tables)

9 Months Ended

Sep. 30, 2011

Net Income per Share [Abstract]

Reconciliation (numerators and denominators) of basic and diluted EPS

The computation for net income per basic and diluted share was:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In thousands)	2011		2010		2011		2010
Numerator
Net income	$	45,916	$	40,189	$	160,447	$	116,334
Add back interest expense for implied conversion of convertible notes, net of estimated tax of $0.5 million for each of the three months ended September 30, 2011 and 2010, respectively, and $1.8 million and $2.1 million for the nine months ended September 30, 2011 and 2010, respectively (see Note 9)		841		987		3,391		3,982
Income used to compute net income per diluted share	$	46,757	$	41,176	$	163,838	$	120,316

Denominator
Total weighted-average shares used to compute net income per basic share		139,680		127,479		139,665		122,209
Effect of dilutive stock options		13		10		13		9
Restricted stock outstanding		12		106		21		99
Assumed conversion of 2012 Notes		-		32,050		19,743		32,050
Assumed conversion of February 2015 Notes		27,314		-		27,314		-
Assumed conversion of 2023 Notes		-		12,572		-		24,081
Shares used to compute income per diluted share		167,019		172,217		186,756		178,448

Net income per basic share	$	0.33	$	0.32	$	1.15	$	0.95
Net income per diluted share	$	0.28	$	0.24	$	0.88	$	0.67

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2011
Fair Value Measurements [Abstract]
Summary of Assets and Liabilities at Fair Value	<div><div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: Times New Roman;">The following table summarizes assets and liabilities recorded at fair value by classification category:</font></div><div style="display: block; text-indent: 0pt;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; font-family: times new roman;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="10" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">September 30, 2011</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="6" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">December 31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr><td align="left" valign="bottom" style="border-bottom: black 2px solid;"><div align="left" style="display: block; margin-left: 9pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">(In thousands)</font></div></td><td valign="bottom" style="border-bottom: black 2px solid;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Level 1</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Level 2</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Total</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Level 1</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Level 2</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;">Total</font></div></td><td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr><td align="left" valign="bottom"><div align="left" style="display: block; margin-left: 9pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Assets:</font></div></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" colspan="2" nowrap="nowrap" valign="bottom"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Money market funds</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">151,497</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">151,497</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">203,318</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">203,318</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Corporate debt securities</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">49,523</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">49,523</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">20,434</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">20,434</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Commercial paper</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">6,943</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">6,943</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">7,998</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">7,998</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">U.S. government sponsored agency bonds</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">6,223</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">6,223</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">8,725</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">8,725</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">U.S. treasury securities</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">5,514</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">5,514</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">1,997</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">1,997</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="28%" style="padding-bottom: 2px;"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Foreign currency hedge contracts</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">11,174</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">11,174</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">17,763</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">17,763</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="28%" style="padding-bottom: 4px;"><div align="left" style="display: block; margin-left: 27pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Total</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">212,757</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">18,117</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">230,874</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">234,474</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">25,761</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">260,235</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="28%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="28%"><div align="left" style="display: block; margin-left: 9pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Liabilities:</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="28%" style="padding-bottom: 4px;"><div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Foreign currency hedge contracts</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">13,883</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">13,883</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">12,810</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">12,810</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"> </font></td></tr></table></div></div>

- Definition

This element represents the disclosure related to assets and liabilities by class, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring and/or nonrecurring basis in periods after initial recognition (for example, impaired assets). The disclosures that may be required or desired include: (a) the fair value measurements recorded during the period and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 33
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 6
-Footnote 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19190-110258

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

+ Details

Cash Equivalents, Short-term and Long-term Investments (Tables)

9 Months Ended

Sep. 30, 2011

Cash Equivalents, Short-term and Long-term Investments [Abstract]

Available-for-sale debt securities

A summary of our available-for-sale securities is presented below:

			Gross		Gross			Estimated
	Amortized		Unrealized		Unrealized			Fair
September 30, 2011:	Cost		Gains		Losses			Value
(In thousands)
Money market funds	$	151,497	$	-	$	-		$	151,497
Corporate debt securities		49,573		27		(77	)		49,523
Commercial paper		6,944		-		(1	)		6,943
U.S. government sponsored agency bonds		6,209		14		-			6,223
U.S. treasury securities		5,493		21		-			5,514
Total	$	219,716	$	62	$	(78	)	$	219,700

December 31, 2010:
(In thousands)
Money market funds	$	203,318	$	-	$	-		$	203,318
Corporate debt securities		20,437		2		(5	)		20,434
Commercial paper		7,998		-		-			7,998
U.S. government sponsored agency bonds		8,727		-		(2	)		8,725
U.S. treasury securities		1,994		3		-			1,997
Total	$	242,474	$	5	$	(7	)	$	242,472

					September 30,			December 31,
Classification on Consolidated Balance Sheets:					2011			2010
(In thousands)
Cash equivalents					$	151,497		$	205,817
Short-term investments						37,847			34,658
Long-term investments						30,356			1,997
Total					$	219,700		$	242,472

Summary of available-for-sale securities

Available-for-sale debt securities by contractual maturity:	September 30, 2011				December 31, 2010
(In thousands)	Amortized		Fair		Amortized		Fair
	Cost		Value		Cost		Value
Less than one year	$	37,852	$	37,847	$	37,162	$	37,157
Greater than one year but less than five years		30,367		30,356		1,994		1,997
Total	$	68,219	$	68,203	$	39,156	$	39,154

- Definition

Tabular disclosure of available-for-sale securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-1
-Paragraph 21
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 17
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 115
-Paragraph 19, 20, 21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27337-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27198-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27161-111563

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27290-111563

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

+ Details

Foreign Currency Hedging (Tables)

9 Months Ended

Sep. 30, 2011

Foreign Currency Hedging [Abstract]

Schedule of foreign currency exchange contracts designated as cash flow hedge

The following table summarizes the notional amounts, Eurodollar exchange rates and fair values of our open Eurodollar contracts designated as cash flow hedges:

				September 30, 2011					December 31, 2010
Eurodollar Forward Contracts				(in thousands)					(in thousands)

Currency	Settlement Price ($ per Eurodollar)		Type	Notional Amount		Fair Value			Notional Amount		Fair Value
Eurodollar		1.400	Sell Eurodollar	$	50,205	$	1,838		$	137,179	$	6,740
Eurodollar		1.200	Sell Eurodollar		117,941		(13,883	)		117,941		(12,810	)
Total				$	168,146	$	(12,045	)	$	255,120	$	(6,070	)

Eurodollar Option Contracts

Currency	Strike Price ($ per Eurodollar)		Type	Notional Amount		Fair Value		Notional Amount		Fair Value
Eurodollar		1.510	Purchased call option	$	54,150	$	46	$	147,957	$	772
Eurodollar		1.315	Purchased call option		129,244		9,290		129,244		10,251
Total				$	183,394	$	9,336	$	277,201	$	11,023

Fair value of foreign currency exchange contracts on condensed consolidated balance sheet

The following table summarizes information about the fair value of our Eurodollar contracts on our Condensed Consolidated Balance Sheets:

		Fair Value (In thousands)
Cash Flow Hedge	Location	September 30, 2011		December 31, 2010
Eurodollar contracts, net	Prepaid and other current assets	$	797	$	5,946
Eurodollar contracts, net	Accrued liabilities		1,993		-
Eurodollar contracts, net	Other long-term liabilities		1,513		993

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579245-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41678-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41638-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5580258-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579240-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41641-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41620-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

+ Details

Prepaid and Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2011

Prepaid and Other Current Assets [Abstract]

Prepaid and Other Current Assets

	September 30,		December 31,
(In thousands)	2011		2010
Non-recourse Notes issuance costs	$	2,009	$	3,362
Foreign exchange hedge		797		5,946
Prepaid taxes		6,051		8,307
Other		820		445
Total prepaid and other current assets	$	9,677	$	18,060

Other Assets (Tables)

9 Months Ended

Sep. 30, 2011

Other Assets, Noncurrent Disclosure [Abstract]

Other Assets

	September 30,		December 31,
(In thousands)	2011		2010
2012 Notes issuance costs	$	-	$	683
February 2015 Notes issuance costs		3,463		4,226
May 2015 Notes issuance costs		4,427		-
Non-recourse Notes issuance costs		-		2,397
Other assets, net		14		-
Total other assets	$	7,904	$	7,306

Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2011

Accrued Liabilities [Abstract]

Schedule of accrued liabilities

	September 30,		December 31,
(In thousands)	2011		2010
Dividend payable	$	21,012	$	20
Foreign currency hedge		1,993		-
Compensation		1,369		349
Interest		3,370		2,794
Deferred revenue		1,713		1,713
Other		1,071		2,328
Total accrued liabilities	$	30,528	$	7,204

Convertible and Non-Recourse Notes (Tables)

9 Months Ended

Sep. 30, 2011

Convertible and Non-Recourse Notes [Abstract]

Convertible and Non-Recourse Notes

Convertible and non-recourse notes activity for the nine months ended September 30, 2011, and fair values at September 30, 2011:

(In thousands)	2012 Notes			February 2015 Notes		May 2015 Notes		Non-recourse Notes			Total
Balance at December 31, 2010	$	133,464		$	176,964	$	-	$	204,270		$	514,698
Issuance		-			-		136,313		-			136,313
Payment		-			-		-		(89,002	)		(89,002	)
Redemption		(133,464	)		-		-		-			(133,464	)
Discount amortization		-			521		1,570		-			2,091
Balance at September 30, 2011	$	-		$	177,485	$	137,883	$	115,268		$	430,636

Fair value(1)	$	-		$	178,650	$	146,420	$	117,573		$	442,643

(1)

As of September 30, 2011, the fair value of the remaining payments under our Convertible notes and Non-recourse Notes was estimated based on the trading value of our notes then outstanding.

May 2015 Notes

The carrying value and unamortized discount of the May 2015 Notes were:

(In thousands)	September 30, 2011
Principal amount of the May 2015 Notes	$	155,250
Unamortized discount of liability component		(17,367	)
Net carrying value of the May 2015 Notes	$	137,883

Interest expense for the May 2015 Notes included in Interest and other expense, net on the Condensed Consolidated Statements of Income was:

(In thousands)	For the Period May 16 to September 30, 2011
Contractual coupon interest	$	2,183
Amortization of debt issuance costs		434
Amortization of debt discount		1,570
Total	$	4,187

Other Long-Term Liabilities (Tables)

9 Months Ended

Sep. 30, 2011

Other Long-Term Liabilities [Abstract]

Other Long-Term Liabilities

	September 30,		December 31,
(In thousands)	2011		2010
Accrued lease liability	$	10,700	$	10,700
Accrued legal settlement		-		27,500
Uncertain tax position		12,615		12,213
Foreign currency hedge		1,513		993
Total	$	24,828	$	51,406

Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2011

Comprehensive Income [Abstract]

Comprehensive Income

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(In thousands)	2011			2010			2011			2010
Net income	$	45,916		$	40,189		$	160,447		$	116,334
Other comprehensive income (loss):
Unrealized gain (loss) on foreign currency exchange contracts, net of taxes		4,281			(15,747	)		(4,981	)		1,341
Unrealized gain (loss) on investments, net of taxes		(55	)		10			(8	)		2
Total comprehensive income	$	50,142		$	24,452		$	155,458		$	117,677

Summary of Significant Accounting Policies (Details)	9 Months Ended
Summary of Significant Accounting Policies (Details)	Sep. 30, 2011	Sep. 30, 2010
Summary of Significant Accounting Policies [Abstract]
Percentage of total royalty revenue by license by product name (in hundredths)	10.00%
Concentration Risk [Line Items]
Maximum total annual milestone payments (in hundredths)	1.00%
Genentech [Member] \| Avastin [Member]
Concentration Risk [Line Items]
Minimum threshold percent of total royalty income requiring disclosure by licence by product name (in hundredths)	29.00%	35.00%
Minimum threshold percent of total royalty income requiring disclosure by licence by product name - year to date (in hundredths)	32.00%	34.00%
Genentech [Member] \| Herceptin [Member]
Concentration Risk [Line Items]
Minimum threshold percent of total royalty income requiring disclosure by licence by product name (in hundredths)	38.00%	32.00%
Minimum threshold percent of total royalty income requiring disclosure by licence by product name - year to date (in hundredths)	36.00%	33.00%
Genentech [Member] \| Lucentis [Member]
Concentration Risk [Line Items]
Minimum threshold percent of total royalty income requiring disclosure by licence by product name (in hundredths)	15.00%	13.00%
Minimum threshold percent of total royalty income requiring disclosure by licence by product name - year to date (in hundredths)	16.00%	14.00%
Elan [Member] \| Tysabri [Member]
Concentration Risk [Line Items]
Minimum threshold percent of total royalty income requiring disclosure by licence by product name (in hundredths)	14.00%	10.00%
Minimum threshold percent of total royalty income requiring disclosure by licence by product name - year to date (in hundredths)	12.00%	10.00%

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Stock-Based Compensation [Abstract]
General and administrative expenses	$ 132	$ 166	$ 256	$ 525
Income tax effect	(46)	(58)	(90)	(184)
Stock-based compensation expense included in net income	$ 86	$ 108	$ 166	$ 341
Shares of restricted stocks issued to employees and members of the board of directors (in shares)	20,000		135,000	40,000
Fully vested stock option (in shares)			1,300,000
Average price of fully vested expired unexercised stock options (dollars per share)			$ 20.36

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References + Details

Net Income per Share (Details)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2011

USD ($)

$ / shares

Sep. 30, 2010

USD ($)

$ / shares

Sep. 30, 2011

USD ($)

$ / shares

Sep. 30, 2010

USD ($)

$ / shares

Debt Instruments [Abstract]

Outstanding stock options excluded from net income per diluted share calculations (in shares)

200,000

400,000

Numerator [Abstract]

Net income | $

$ 45,916

$ 40,189

$ 160,447

$ 116,334

Add back | $

^[1]

841

987

3,391

3,982

Income used to compute net income per diluted share | $

$ 46,757

$ 41,176

$ 163,838

$ 120,316

Denominator [Abstract]

Total weighted-average shares used to compute basic income per share (in shares)

139,680,000

127,479,000

139,665,000

122,209,000

Effect of dilutive stock options (in shares)

13,000

10,000

13,000

9,000

Restricted stock outstanding (in shares)

12,000

106,000

21,000

99,000

Shares used to compute income per diluted share (in shares)

167,019,000

172,217,000

186,756,000

178,448,000

Net Income per Basic Share [Abstract]

Net income per basic share (dollars per share) | $ / shares

$ 0.33

$ 0.32

$ 1.15

$ 0.95

Net income per diluted share (dollars per share) | $ / shares

$ 0.28

$ 0.24

$ 0.88

$ 0.67

Estimated tax on convertible note interest expense (1) | $

$ 500

$ 1,800

$ 2,100

Due 2012 [Member]

Debt Instruments [Abstract]

Interest rate of convertible note (in hundredths)

2.00%

Assumed conversion of debt notes (in shares)

32,050

19,743

32,050

Due February 2015 [Member]

Debt Instruments [Abstract]

Interest rate of convertible note (in hundredths)

2.875%

Conversion ratio in shares (in shares)

151.713

Conversion price (dollars per share) | $ / shares

$ 6.59

Assumed conversion of debt notes (in shares)

27,314

Due 2023 [Member]

Debt Instruments [Abstract]

Interest rate of convertible note (in hundredths)

2.75%

Assumed conversion of debt notes (in shares)

12,572

24,081

Due May 2015 [Member]

Debt Instruments [Abstract]

Interest rate of convertible note (in hundredths)

3.75%

Conversion ratio in shares (in shares)

132.6682

Conversion price (dollars per share) | $ / shares

$ 7.54

[1]	Interest expense for convertible notes, net of estimated tax of $0.5 million for each of the three months ended September 30, 2011 and 2010, respectively, and $1.8 million and $2.1 million for the nine months ended September 30, 2011 and 2010, respectively (see Note 9)

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Assets:
Money market funds	$ 151,497	$ 203,318
Corporate debt securities	49,523	20,434
Commercial paper	6,943	7,998
U.S. government sponsored agency bonds	6,223	8,725
U.S. treasury securities	5,514	1,997
Foreign currency hedge contracts	11,174	17,763
Total	230,874	260,235
Liabilities:
Foreign currency hedge contracts	13,883	12,810
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Assets:
Money market funds	151,497	203,318
Corporate debt securities	49,523	20,434
Commercial paper	0	0
U.S. government sponsored agency bonds	6,223	8,725
U.S. treasury securities	5,514	1,997
Foreign currency hedge contracts	0	0
Total	212,757	234,474
Liabilities:
Foreign currency hedge contracts	0	0
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Assets:
Money market funds	0	0
Corporate debt securities	0	0
Commercial paper	6,943	7,998
U.S. government sponsored agency bonds	0	0
U.S. treasury securities	0	0
Foreign currency hedge contracts	11,174	17,763
Total	18,117	25,761
Liabilities:
Foreign currency hedge contracts	$ 13,883	$ 12,810

Cash Equivalents, Short-term and Long-term Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Cash Equivalents Items [Line Items]
Amortized Cost	$ 219,716	$ 242,474
Gross Unrealized Gains	62	5
Gross Unrealized Losses	(78)	(7)
Estimated Fair Value	219,700	242,472
Classification on Condensed Consolidated Balance Sheets:
Cash equivalents	151,497	205,817
Short-term investments	37,847	34,658
Long-term investments	30,356	1,997
Summary portfolio available-for-sale debt securities, by contractual maturity, amortized cost [Abstract]
Less than one year	37,852	37,162
Greater than one year but less than five years	30,367	1,994
Available for sale securities debt maturities, total cost basis	68,219	39,156
Summary portfolio available-for-sale debt securities, by contractual maturity, fair value [Abstract]
Less than one year	37,847	37,157
Greater than one year but less than five years	30,356	1,997
Available for sale securities debt maturities, total fair value	68,203	39,154
Money Market Funds [Member]
Cash Equivalents Items [Line Items]
Amortized Cost	151,497	203,318
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	151,497	203,318
Corporate Debt Securities [Member]
Cash Equivalents Items [Line Items]
Amortized Cost	49,573	20,437
Gross Unrealized Gains	27	2
Gross Unrealized Losses	(77)	(5)
Estimated Fair Value	49,523	20,434
Commercial Paper [Member]
Cash Equivalents Items [Line Items]
Amortized Cost	6,944	7,998
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	0
Estimated Fair Value	6,943	7,998
US Government Corporations and Agencies Securities [Member]
Cash Equivalents Items [Line Items]
Amortized Cost	6,209	8,727
Gross Unrealized Gains	14	0
Gross Unrealized Losses	0	(2)
Estimated Fair Value	6,223	8,725
US Treasury Securities [Member]
Cash Equivalents Items [Line Items]
Amortized Cost	5,493	1,994
Gross Unrealized Gains	21	3
Gross Unrealized Losses	0	0
Estimated Fair Value	$ 5,514	$ 1,997

Foreign Currency Hedging (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
Foreign Currency Hedging (Details) $ in Thousands	Sep. 30, 2011 USD ($) $ / shares	Sep. 30, 2010 USD ($)	Sep. 30, 2011 USD ($) $ / shares	Sep. 30, 2010 USD ($)	Dec. 31, 2010 USD ($) $ / shares
Derivatives, Fair Value [Line Items]
Unrealized net loss on effective component of Eurodollar contracts, net of tax			$ 1,800
Unrealized net gain on effective component of Eurodollar contracts, net of tax					$ 3,200
Royalty revenue recognized from settled Eurodollar contracts	$ (700)	$ 2,900	200	$ 4,500
Expected amount to be reclassified from other comprehensive loss against earnings	800		800
Other Long-Term Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange contracts (net)	1,513		1,513		(993)
Foreign Currency Hedge-Current [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange contracts (net)	797		797		5,946
Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange contracts (net)	1,993		1,993		0
Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount	168,146		168,146		255,120
Fair value	$ (12,045)		$ (12,045)		$ (6,070)
Foreign Exchange Forward [Member] \| Eurodollar Sell Forward Contract 1.400 [Member]
Derivative [Line Items]
Settlement price (in US dollars per Eurodollar) \| $ / shares	1.400		1.400		1.400
Notional amount	$ 50,205		$ 50,205		$ 137,179
Fair value	$ 1,838		$ 1,838		$ 6,740
Foreign Exchange Forward [Member] \| Eurodollar Sell Forward Contract 1.200 [Member]
Derivative [Line Items]
Settlement price (in US dollars per Eurodollar) \| $ / shares	1.200		1.200		1.200
Notional amount	$ 117,941		$ 117,941		$ 117,941
Fair value	(13,883)		(13,883)		(12,810)
Foreign Exchange Option [Member]
Derivative [Line Items]
Notional amount	183,394		183,394		277,201
Fair value	$ 9,336		$ 9,336		$ 11,023
Foreign Exchange Option [Member] \| Eurodollar Purchased Call Option 1.510 [Member]
Derivative [Line Items]
Strike price (in US dollars per Eurodollar) \| $ / shares	1.510		1.510		1.510
Notional amount	$ 54,150		$ 54,150		$ 147,957
Fair value	$ 46		$ 46		$ 772
Foreign Exchange Option [Member] \| Eurodollar Purchased Call Option 1.315 [Member]
Derivative [Line Items]
Strike price (in US dollars per Eurodollar) \| $ / shares	1.315		1.315		1.315
Notional amount	$ 129,244		$ 129,244		$ 129,244
Fair value	$ 9,290		$ 9,290		$ 10,251

Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Prepaid and Other Current Assets [Abstract]
Non-recourse Notes issuance costs	$ 2,009	$ 3,362
Foreign exchange hedge	797	5,946
Prepaid taxes	6,051	8,307
Other	820	445
Total prepaid and other current assets	$ 9,677	$ 18,060

Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Other Assets, Noncurrent Disclosure [Abstract]
2012 Notes issuance costs	$ 0	$ 683
February 2015 Notes issuance costs	3,463	4,226
May 2015 Notes issuance costs	4,427	0
Non-recourse Notes issuance costs	0	2,397
Other assets, net	14	0
Total other assets	$ 7,904	$ 7,306

Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Accrued Liabilities [Abstract]
Dividend payable	$ 21,012	$ 20
Foreign currency hedge	1,993	0
Compensation	1,369	349
Interest	3,370	2,794
Deferred revenue	1,713	1,713
Other	1,071	2,328
Total accrued liabilities	$ 30,528	$ 7,204

- Definition

Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References + Details

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References + Details

Convertible and Non-Recourse Notes (Details)
$ in Thousands

3 Months Ended

9 Months Ended

Jun. 30, 2011

USD ($)

Sep. 30, 2011

USD ($)

$ / shares

Sep. 30, 2010

USD ($)

May 16, 2011

USD ($)

Convertible and Non-Recourse Notes [Line Items]

Balance at December 31, 2010

$ 514,698

Issuance

136,313

Repayment of non-recourse notes

(89,002)

$ (74,959)

Redemption

(133,464)

Discount amortization

2,092

Balance at September 30, 2011

430,637

Fair value

^[1]

442,643

Interest expense for the May 2015 Notes [Abstract]

Amortization of debt issuance costs

3,592

1,210

Net carrying value of the May 2015 Notes [Abstract]

Principal Amount of the May 2015 Notes

155,250,000

Unamortized discount of liability component

(17,367,000)

$ (18,900)

Net carrying value of the May 2015 Notes

$ 137,883,000

May 2015 Notes - Purchased call options [Abstract]

Number of hedge counterparties

Number of shares of the Company's common stock entitled to the Company to purchase (in shares) | shares

19,600,000

Call option strike price of common share (dollars per share) | $ / shares

7.54

Number of warrants exercisable, on a cashless basis, sold to the hedge counterparties (in shares) | shares

27,500,000

Purchased call option strike price of common shares (dollars per share) | $ / shares

7.54

Company's common stock strike price per warrant (dollars per share) | $ / shares

8.87

Purchased call option and warrants assumed conversion and exercise

If the share price is above $7.54, upon conversion of the May 2015 Notes, the purchased call options will offset the share dilution, because the Company will receive shares on exercise of the purchased call options equal to the shares that the Company must deliver to the note holders. If the share price is above $8.87, upon exercise of the warrants, the Company will deliver shares to the counterparties in an amount equal to the excess of the share price over $8.87. For example, a 10 increase in the share price above 8.87 would result in the issuance of 1.9 million incremental shares upon exercise of the warrants. As our share price continues to increase, additional dilution would occur.

Purchased call options cost

$ 20,700

Deferred taxes on purchased call options cost

7,200

Proceeds received on sale of warrants rights

$ 10,868

$ 0

Number of shares of common stock covered by the purchased call options purchased (in shares) | shares

20,600,000

Purchased call options expiration

May 1, 2015, or the last day any of the May 2015 Notes remain outstanding

Warrants expiration range, minimum

Jul. 30, 2015

Warrants expiration range, maximum

Jan. 20, 2016

Redemption of 2012 Notes [Abstract]

Amount redeemed in aggregate principal outstanding

$ 133,500

Redemption price of face value (in hundredths)

100.29%

Aggregate consideration of redemption

$ 133,900

Aggregate consideration paid for interest related to redemption

$ 1,000

Convertible 2012 Notes [Member]

Convertible and Non-Recourse Notes [Line Items]

Balance at December 31, 2010

$ 133,464

Issuance

Repayment of non-recourse notes

Redemption

(133,464)

Discount amortization

Balance at September 30, 2011

Fair value

^[1]

Convertible Fedruary 2015 Notes [Member]

Convertible and Non-Recourse Notes [Line Items]

Balance at December 31, 2010

176,964

Issuance

Repayment of non-recourse notes

Redemption

Discount amortization

521

Balance at September 30, 2011

177,485

Fair value

^[1]

178,650

Convertible May 2015 Notes [Member]

Convertible and Non-Recourse Notes [Line Items]

Balance at December 31, 2010

Issuance

136,313

Repayment of non-recourse notes

Redemption

Discount amortization

1,570

Balance at September 30, 2011

137,883

Fair value

^[1]

146,420

Interest expense for the May 2015 Notes [Abstract]

Contractual coupon interest

^[2]

2,183

Amortization of debt issuance costs

^[2]

434

Amortization of debt discount

^[2]

1,570

Total

^[2]

4,187

Net proceeds on debt issuance

$ 149,700

Maturity date

May 01, 2015

Conversion ratio in shares (in shares) | shares

132.6682

Conversion price (dollars per share) | $ / shares

$ 7.54

Debt stated interest rate (in hundredths)

3.75%

Convertible notes repurchase price as a percentage of principal (in hundredths)

100.00%

Convertible debt conversion features

During any fiscal quarter ending after the quarter ending June 30, 2011, if the last reported sale price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter exceeds 130% of the conversion price for the notes on the last day of such preceding fiscal quarter; During the five business-day period immediately after any five consecutive trading-day period, which we refer to as the measurement period, in which the trading price per 1,000 principal amount of notes for each trading day of that measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the notes for each such day; or Upon the occurrence of specified corporate events as described further in the indenture at any time on or after November 1, 2014.

Assumed borrowing rate on equity component of notes obligation (in hundredths)

7.50%

Notes obligation allocated to additional paid-in capital

$ 12,300

Noted obligation allocated to deferred tax liability

$ 6,600

Effective interest rate (in hundredths)

7.50%

Remaining discount amortization period (in years)

3.6

Non-Recourse Notes [Member]

Convertible and Non-Recourse Notes [Line Items]

Balance at December 31, 2010

$ 204,270

Repayment of non-recourse notes

(89,002)

Redemption

Discount amortization

Balance at September 30, 2011

115,268

Fair value

^[1]

$ 117,573

[1]	As of September 30, 2011, the fair value of the remaining payments under our Convertible notes and Non-recourse Notes was estimated based on the trading value of our notes then outstanding.
[2]	For the Period May 16 to June 30, 2011

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2011 USD ($)	Dec. 31, 2010 USD ($)
Guarantor Obligations [Line Items]
Number of PDL's claims for relief relating to the 2003 settlement agreement	4
Number of PDL's claims dismissed by the court	1
Redwood City Facilities [Member]
Guarantor Obligations [Line Items]
Total lease payments guarantee, maximum exposure	$ 113.4
Estimated fair value of guarantee liability	$ 10.7	$ 10.7

Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Comprehensive Income (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Comprehensive Income [Abstract]
Net income	$ 45,916	$ 40,189	$ 160,447	$ 116,334
Other comprehensive income:
Unrealized gain (loss) on foreign currency exchange contracts, net of taxes	4,281	(15,747)	(4,981)	1,341
Unrealized loss on investments, net of taxes	(55)	10	(8)	2
Total comprehensive income	$ 50,142	$ 24,452	$ 155,458	$ 117,677

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 8, 9, 10, 11, 12, 13, 14
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A5
-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6508144

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 87-21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 10, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28, 29, 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 19

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A7
-Appendix A

+ Details

- Definition

Change in accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges, net of tax effect. The after tax effect change includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 121
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Appreciation or loss in value (before reclassification adjustment) of the total of unsold securities during the period being reported on, net of tax. Reclassification adjustments include: (1) the unrealized holding gain (loss), net of tax, at the date of the transfer for a debt security from the held-to-maturity category transferred into the available-for-sale category. Also includes the unrealized gain (loss) at the date of transfer for a debt security from the available-for-sale category transferred into the held-to-maturity category; (2) the unrealized gains (losses) realized upon the sale of securities, after tax; and (3) the unrealized gains (losses) realized upon the write-down of securities, after tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 115
-Paragraph 13
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Other Long-Term Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Other Long-Term Liabilities [Abstract]
Accrued lease liability	$ 10,700	$ 10,700
Accrued legal settlement	0	27,500
Uncertain tax position	12,615	12,213
Foreign currency hedge	1,513	993
Total	$ 24,828	$ 51,406

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Income Taxes [Abstract]
Income tax expense	$ 25.0	$ 23.0	$ 87.0	$ 70.8
Federal statutory income tax rate (in hundredths)	35.00%	35.00%	35.00%	35.00%

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to pretax Income or Loss from continuing operations; income tax expense or benefit may include interest and penalties on tax uncertainties based on the entity's accounting policy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 48
-Paragraph 15, 16, 19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45, 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e32247-109318

+ Details

Cash Dividends (Details)	3 Months Ended			9 Months Ended
Cash Dividends (Details)	Sep. 30, 2011 USD ($) $ / shares	Jun. 30, 2011 USD ($)	Mar. 31, 2011 USD ($)	Sep. 30, 2011 USD ($) $ / shares	Feb. 25, 2011 $ / shares
Cash Dividends [Abstract]
Cash dividends, declaration date					2011-02-25
Quarterly dividend per share (in dollars per share) \| $ / shares					$ 0.15
Quarterly dividend, date of record					March 8, June 8, September 8 and December 8 of 2011
Quarterly dividend, payable date					March 15, June 15, September 15 and December 15 of 2011
Dividend payments	$ 21,000,000	$ 21,000,000	$ 21,000,000
Dividends accrued for last quarter of 2011	21,000,000			$ 21,000,000
Due February 2015 [Member]
Debt Instrument [Line Items]
Adjusted conversion ratio for 2015 Notes (in shares)				151.713
Principal amount of convertible notes	$ 1,000			$ 1,000
Conversion price of convertible notes (in dollars per share) \| $ / shares	$ 6.59			$ 6.59
Due May 2015 [Member]
Debt Instrument [Line Items]
Adjusted conversion ratio for 2015 Notes (in shares)				132.6682
Principal amount of convertible notes	$ 1,000			$ 1,000
Conversion price of convertible notes (in dollars per share) \| $ / shares	$ 7.54			$ 7.54